Document Details
Form
Filing Date
Jan 6, 2020
Document Date
Jan 2, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Akero Therapeutics, Inc.
Issuer
Akero Therapeutics, Inc.
Filer
Versant Venture Capital VI, L.P.